Calculated based on number of publications stored in Pure and citations from Scopus
1989 …2022

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Kiyoshi Kubota

  • Faculty of Medicine
  • Drug Safety Research Unit Japan
  • Department of Pharmacoepidemiology
  • The University of Tokyo
  • Department of Pharmacoepidemiology
  • NPO Drug Safety Research Unit Japan
  • Japanese Society for Pharmacoepidemiology
  • Department of Pharmacoepidemiolog
  • NPO Drug Safety Research Unit Japan
  • Tokyo University of Science

External person

Nobuhiro Ooba

  • Department of Pharmacoepidemiology
  • The University of Tokyo
  • Department of Pharmacoepidemiology
  • NPO Drug Safety Research Unit Japan
  • Department of Clinical Pharmacy
  • Nihon University
  • Department of Pharmacoepidemiolog

External person

Hitomi Motomura

  • Department of Medicinal and Life Science
  • Center for Translational Research
  • Tokyo University of Science

External person

Chotaro Onaga

  • Department of Medicinal and Life Science
  • Tokyo University of Science

External person

Ayaka Ozaki

  • Tokyo University of Science

External person

Michio Kimura

  • Department of Medical Informatics
  • Hamamatsu University School of Medicine
  • Japan Association for Medical Informatics
  • Tokoha University

External person

Yea Huei Kao Yang

  • School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences
  • National Cheng Kung University
  • Institute of Clinical Pharmacy and Pharmaceutical Sciences, Health Outcome Research Centre

External person

Nicole L. Pratt

  • Quality Use of Medicines and Pharmacy Research Centre
  • University of South Australia

External person

Yasushi Hara

  • Research Institute for Biomedical Sciences
  • Tokyo University of Science
  • Tokyo Women's Medical University
  • Institute for Biological Sciences

External person

Elizabeth E. Roughead

  • Quality Use of Medicines and Pharmacy Research Centre
  • University of South Australia

External person

Takuhiro Yamaguchi

  • School of Health Sciences and Nursing
  • The University of Tokyo
  • Tohoku University
  • Division of Biostatistics
  • Department of Public Health and Forensic Medicine
  • Department of Clinical Trial Data Management

External person

Nam Kyong Choi

  • Division of Pharmacoepidemiology and Pharmacoeconomics
  • Harvard University
  • Seoul National University
  • Medical Research Collaborating Centre
  • Medical Research Collaborating Centre
  • Institute of Environmental Medicine
  • Medical Research Collaborating Centre

External person

Tomomi Kimura

  • Astellas Pharma Inc.
  • Department of Medical Informatics
  • Hamamatsu University School of Medicine
  • Tokoha University

External person

Ju Young Shin

  • Department of Epidemiology
  • McGill University
  • Department of Preventative Medicine
  • Seoul National University
  • Korea Institute of Drug Safety and Risk Management
  • Korea Institute of Drug Safety and Risk Management

External person

Edward Chia Cheng Lai

  • School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences
  • National Cheng Kung University
  • Institute of Clinical Pharmacy and Pharmaceutical Sciences, Health Outcome Research Centre

External person

Byung Joo Park

  • Department of Preventive Medicine
  • Seoul National University
  • Department of Preventative Medicine
  • Medical Research Collaborating Centre
  • Department of Preventative Medicine
  • Korea Institute of Drug Safety and Risk Management
  • Korea Institute of Drug Safety and Risk Management
  • Department of Preventative Medicine

External person

Kazunori Sasaki

  • Yokohama City University
  • Department of Molecular Biology
  • Department of Molecular Biology
  • Molecular Biology
  • Departments of Molecular Biology
  • Juntendo University

External person

Esther W. Chan

  • Centre for Safe Medication Practice and Research
  • The University of Hong Kong

External person

Ian C.K. Wong

  • Centre for Safe Medication Practice and Research
  • Research Department of Practice and Policy
  • University College London
  • The University of Hong Kong

External person

Soko Setoguchi

  • Duke University
  • Department of Pharmacoepidemiology
  • The University of Tokyo
  • NPO Drug Safety Research Unit Japan
  • Rutgers - The State University of New Jersey, New Brunswick

External person

K. Katahira

  • Tokyo Medical and Dental University

External person

Kenneth K.C. Man

  • Centre for Safe Medication Practice and Research
  • The University of Hong Kong

External person

Shigeo Ohno

  • Yokohama City University
  • Department of Molecular Biology
  • Department of Molecular Biology
  • Advanced Medical Research Centre
  • Departments of Molecular Biology
  • Molecular Biology
  • Tokyo Metropolitan Institute of Medical Science
  • Juntendo University

External person

Eiji Kawakami

  • Japan Pharmaceutical Association

External person

Ulf Bergman

  • Centre for Pharmacoepidemiology, Karolinska Institutet
  • Karolinska Institutet
  • Division of Clinical Pharmacology

External person

Makoto Ushida

  • Meijo University

External person

Masaomi Kimura

  • Shibaura Institute of Technology

External person

Akira Kokan

  • Eli Lilly
  • Japanese Society for Pharmacoepidemiology

External person

Keisuke Aoe

  • Department of Respiratory Medicine
  • National Hospital Organization, Japan

External person

Akira Sakuma

  • Department of Clinical Pharmacology
  • Tokyo Medical and Dental University

External person

Daisuke Koide

  • Japanese Society for Pharmacoepidemiology
  • Department of Clinical Epidemiology and Systems
  • The University of Tokyo

External person

Kenichi Gemba

  • Department of Respiratory Medicine
  • Japan Organization of Occupational Health and Safety

External person

Morten Andersen

  • Centre for Pharmacoepidemiology, Karolinska Institutet
  • Karolinska Institutet
  • Division of Clinical Pharmacology

External person

Yohei Miyagi

  • Kanagawa Cancer Center
  • Kanagawa Cancer Center Res. Inst.
  • Division of Tumor Pathology

External person

CHIKA MATSUDA

  • Tokyo University of Science

External person

Yoshiaki Shikamura

  • Emuzu Pharmacy
  • Faculty of Pharmaceutical Sciences
  • Tokyo University of Science
  • Emuzu Pharmacy

External person

Tuan Anh Nguyen

  • Quality Use of Medicines and Pharmacy Research Centre
  • University of South Australia

External person

David W. Kaufman

  • Boston University

External person

Tong Tong Wang

  • Marketed Health Products Directorate
  • Health Canada

External person

H. Ishiguro

  • Department of Urology
  • Yokohama City University
  • Kanagawa Academy of Science and Technology
  • Photocatalyst Group
  • Department of Urology
  • Kanagawa Institute of Industrial Science and Technology
  • Kanagawa Institute of Industrial Science and Technology

External person

Yuka Nagashima

  • Tokyo University of Science

External person

Tobias Gerhard

  • Institute for Health, Health Care Policy and Aging Research
  • Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy
  • Rutgers - The State University of New Jersey, Newark
  • Rutgers - The State University of New Jersey, New Brunswick

External person

Takumi Kishimoto

  • Department of Respiratory Medicine
  • Japan Organization of Occupational Health and Safety

External person

Kazunori Sasaki

  • Juntendo University

External person

Marina Nagamura

  • Nihon University

External person

IZUMI MATSUOKA

  • Tokyo University of Science

External person

Shigeru Kageyama

  • Division of Clinical Pharmacology and Therapeutics
  • The Jikei University School of Medicine
  • Japanese Society of Clinical Pharmacology and Therapeutics

External person

Shigeo Ohno

  • Juntendo University

External person

Anders Sundström

  • Centre for Pharmacoepidemiology, Karolinska Institutet
  • Karolinska Institutet
  • Division of Clinical Pharmacology

External person

Yukari Kamijima

  • Non-Profitable Organization
  • Drug Safety Research Unit Japan
  • Drug Safety Research Unit Japan
  • Department of Pharmacoepidemiology
  • The University of Tokyo

External person

Hikaru Watanabe

  • Department of Pharmacoepidemiology
  • The University of Tokyo
  • Department of Pharmacoepidemiolog
  • Drug Safety Research Unit Japan

External person

Shotaro Kanai

  • Tokyo University of Science

External person

Yuyun Xiong

  • Tokyo University of Science
  • Jiangsu University

External person

Cecilia Huang

  • Institute for Health, Health Care Policy and Aging Research
  • Rutgers - The State University of New Jersey, New Brunswick
  • Rutgers - The State University of New Jersey, Newark
  • Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy

External person

Jenna Griffiths

  • Marketed Health Products Directorate
  • Health Canada

External person

Kouji Yamamoto

  • Yokohama City University
  • Department of Biostatistics
  • Center for Translational Research
  • Tokyo University of Science

External person

Katsuya Kato

  • Department of Radiology
  • Okayama University

External person

Junichi Tokuyoshi

  • Japan Pharmaceutical Association

External person

Choichiro Miyazaki

  • Japan Pharmaceutical Association

External person

Shuko Nojiri

  • Department of Pharmacoepidemiology
  • The University of Tokyo

External person

Jessica Jalbert

  • Harvard University
  • Department of Medicine

External person

Yoji Nagashima

  • Tokyo Women's Medical University

External person

Hitoshi Shimomura

  • Faculty of Pharmaceutical Sciences
  • Tokyo University of Science
  • International University of Health and Welfare
  • Department of Pharmacy
  • International University of Health and Welfare
  • Kaken Hospital

External person

Kazuhiro Watanabe

  • Department of Pharmacy Practice
  • Showa Pharmaceutical University

External person

Miwako Kamei

  • Teikyo Heisei University

External person

Thu Lan Kelly

  • University of South Australia

External person

Hidenori Masuyama

  • Kaken Hospital
  • International University of Health and Welfare

External person

Masao Takahashi

  • Japan Pharmaceutical Association

External person

Junji Yoshino

  • Banbuntane Hotokukai Hospital
  • Fujita Health University

External person

Heung Woo Park

  • Seoul National University

External person

Masa Aki Yatani

  • Tokyo University of Science

External person

Masahiro Tohkin

  • Nagoya City University

External person

Kentaro Sugano

  • Jichi Medical University

External person

Namiki Fujii

  • Department of Molecular Pathology and Metabolic Disease
  • Tokyo University of Science
  • Faculty of Pharmaceutical Sciences

External person

Hiroki Sugimori

  • Department of Preventive Medicine
  • Daito Bunka University

External person

Katsunori Saigenji

  • Department of Internal Medicine
  • Kitasato University

External person

Yuko Shirakuni

  • Osaka University
  • Graduate School of Pharmaceutical Sciences

External person

Masao Nasu

  • Osaka University
  • Graduate School of Pharmaceutical Sciences
  • Graduate School of Pharmaceutical Sciences

External person

Maho Kotori

  • Tokyo University of Science

External person

Reika Katayama

  • Department of Medicinal and Life Science
  • Tokyo University of Science
  • Department of Medicinal and Life Science

External person

Carla van Bennekom

  • Boston University

External person

Eriko Kikuchi

  • Department of Medicinal and Life Science
  • Tokyo University of Science

External person

Fumio Okuyama

  • Department of Ophthalmology
  • Tokyo Medical and Dental University

External person

Ken Toyoda

  • Japan Association for Medical Informatics

External person

Yumiko Kimura

  • Tokyo University of Science

External person

Mitsuaki Shimada

  • Japan Pharmaceutical Association

External person

Chihiro Ohira

  • Tokyo University of Science

External person

Yoji Nagashima

  • Department of Molecular Pathology
  • Yokohama City University
  • Dept. of Second Div. of Pathology
  • Tokyo Women's Medical University
  • Department of Molecular Pathology
  • Department of Surgical Pathology
  • Department of Surgical Pathology
  • Advanced Medical Research Centre
  • Department of Molecular Pathology
  • Molecular Pathology
  • Department of Molecular Pathology
  • Department of Molecular Pathology
  • Departments of Molecular Pathology
  • Deparment of Molecular Pathology

External person

Tsutomu Chiba

  • Department of Gastroenterology and Hepatology
  • Kyoto University
  • Graduate School of Medicine
  • Division of Gastroenterology

External person

Seira Uta

  • Department of Molecular Pathology and Metabolic Disease
  • Tokyo University of Science

External person

Kenichi Matsui

  • Office for Promoting Medical Research
  • Showa University

External person

Naoyuki Okita

  • Department of Molecular Pathology and Metabolic Disease
  • Tokyo University of Science
  • Department of Biochemistry
  • Center for Translational Research
  • Department of Internal Medicine Research
  • Sasaki Institute
  • Division of Pathological Biochemistry
  • Sanyo-Onoda City University
  • Faculty of Pharmaceutical Sciences
  • The Jikei University School of Medicine
  • Division of Translational and Molecular Medicine
  • Department of Molecular Metabolic Regulation Research
  • Department of Biochemistry
  • Genome and Drug Research Center
  • Faculty of Pharmaceutical Sciences
  • Yamaguchi Tokyo University of Science

External person

Takashi Ando

  • Division of Evaluation and Analysis of Drug Information
  • Keio University

External person

Steffen Amann

  • Klinikum Bogenhausen

External person

Yuko Waki

  • Tokyo University of Science

External person

Masao Kawaguchi

  • Department of Pharmacy
  • Tokyo Medical and Dental University

External person

Koji Shomoto

  • Pharmaceutical Research and Manufacturers of America (PhRMA

External person

Hajime Iizuka

  • Department of Dermatology
  • Asahikawa Medical University

External person

Akira Wakana

  • MSD K.K.
  • Kitanomaru Square

External person

Masao Takahashi

  • Japan Pharmaceutical Association

External person

Urban Ösby

  • Neurogenetics Unit, Department of Molecular Medicine and Surgery
  • Karolinska Institutet

External person

Atsushi Yoshimori

  • Institute for Theoretical Medicine, Inc.
  • Department of Biochemistry
  • Tokyo University of Science
  • Department of Biochemistry
  • Genome and Drug Research Center
  • Institute for Theoretical Medicine, Inc.
  • Research Institute for Biomedical Sciences
  • Institute for Theoretical Medicine, Inc.
  • Tokyo Institute of Technology
  • Institute for Theoretical Medicine Inc.
  • Institute for Theoretical Medicine, Inc.
  • Institute for Theoretical Medicine, Inc.
  • Institute for Theoretical Medicine Inc.
  • Genome and Drug Research Center
  • Department of Biochemistry
  • Kyo University of Science
  • Institute for Theoretical Medicine, Inc. 1-1-5-504 Uchikanda
  • Inc.

External person

Toru Majima

  • Kaken Hospital
  • International University of Health and Welfare

External person

S. Ueda

  • Yokohama City University
  • Japanese Society of Clinical Pharmacology and Therapeutics

External person

Keiko Imanaka

  • Kaken Hospital
  • International University of Health and Welfare

External person

Tetsuya Mine

  • School of Medicine
  • Tokai University

External person

Yuji Kumagai

  • Kitasato University
  • Department of Pharmacology

External person

Yuyun Xiong

  • Tokyo University of Science

External person

Yasuo Ohashi

  • Department of Biostatistics
  • The University of Tokyo
  • Department of Biostatistics
  • Japan Society of Clinical Trials and Research
  • Chuo University
  • Tokyo University of Agriculture and Technology

External person

Nanako Mochizuki

  • Tokyo University of Science

External person

Mitsuaki Shimada

  • Japan Pharmaceutical Association

External person

Hiromi Nakane

  • Department of Medicinal and Life Science
  • Tokyo University of Science
  • Department of Medicinal and Life Science

External person

Kaori Nomura

  • The Jikei University School of Medicine

External person

Osamu Komiyama

  • Federation of Pharmaceutical Manufacturer's Associations of Japan

External person

Hajime Kuwayama

  • Dokkyo Medical University
  • Dokkyo University
  • University Hospital at Koshigaya

External person

Ayano Namiki

  • Tokyo University of Science

External person

Takeo Nakayama

  • Department of Health Informatics
  • Kyoto University

External person

Yuji Mizokami

  • Kasumigaura Hospital
  • Tokyo Medical University

External person

Nobuhiro Sakaki

  • Tokyo Metropolitan Bokutoh Hospital

External person

Hidenori Shinoda

  • Japan Association of Healthcare Information Systems Industry (JAHIS

External person

Masaki Kitamura

  • The Jikei University School of Medicine

External person

Yukio Yoshida

  • Jichi Medical School
  • Jichi Medical University

External person

Tooru Shimosegawa

  • Graduate School of Medicine
  • Tohoku University

External person

Ken Yamamoto

  • Department of Pharmacy Practice
  • Showa Pharmaceutical University

External person

Machi Suka

  • Department of Public Health and Environmental Medicine
  • The Jikei University School of Medicine

External person

Yuka Ishihara

  • Tokyo University of Science

External person

Yoshinori Takahashi

  • Japan Pharmaceutical Association

External person

Koji Yakabi

  • School of Medicine
  • Teikyo University

External person

Akari Matsuda

  • Tokyo University of Science

External person

Chiharu Nakami

  • Department of Medical Computer
  • Tokyo Medical and Dental University

External person

Airi Ono

  • Tokyo University of Science

External person

Nami Shimada

  • Department of Pharmacy
  • Tokyo University of Science
  • Faculty of Pharmaceutical Sciences

External person

Mei Noike

  • Department of Medicinal and Life Science
  • Tokyo University of Science

External person

Yukihiro Sakurai

  • Nippon Telegraph & Telephone

External person

Takao Orii

  • Nippon Telegraph & Telephone

External person

Masaki Fukushima

  • Department of Clinical Pharmacology
  • Tokyo Medical and Dental University

External person

Michiko Yamamoto

  • Department of Drug Informatics
  • Showa Pharmaceutical University

External person

Hirohisa Doi

  • Department of Drug Informatics
  • Showa Pharmaceutical University

External person

Yoshinori Takahashi

  • Japan Pharmaceutical Association

External person

Hiroshi Yoshida

  • Department of Laboratory Medicine
  • The Jikei University School of Medicine

External person

Xue Mei Jin

  • Department of Preventive Medicine
  • Seoul National University

External person

Hidemi Nakagawa

  • Department of Dermatology
  • The Jikei University School of Medicine
  • Jichi Medical University
  • Department of Dermatology
  • Department of Dermatology

External person

Misa Imai

  • Department of Hematology
  • Juntendo University
  • Atopy (Allergy) Research Center

External person

Choitsu Sakamoto

  • Nippon Medical School

External person

Mizuki Fujita

  • Tokyo University of Science

External person

Tetsuo Arakawa

  • Osaka City University
  • Osaka Metropolitan University

External person

Yoshiro Saito

  • National Institute of Health Sciences Tokyo

External person

Keiko Goto

  • Faculty of Pharmaceutical Sciences
  • Research Institute for Science and Technology
  • Tokyo University of Science

External person

TAKUMA FUJITA

  • Tokyo University of Science

External person

Joongyub Lee

  • Medical Research Collaborating Centre
  • Seoul National University

External person

Jane E. Sheehan

  • Boston University

External person

Taka Aki Shiina

  • Tokyo University of Science

External person

Hiroyuki Osawa

  • Jichi Medical University

External person

Ryo Abe

  • Division of Immunobiology
  • Genome and Drug Research Center
  • Research Institute for Biomedical Sciences
  • Tokyo University of Science
  • Center for Technologies Against Cancer
  • Center for Animal Disease Models
  • Division of Medical-Science-Engineering Cooperation
  • Strategic Innovation and Research Center
  • Teikyo University
  • Research Institute for Science and Technology
  • Faculty of Pharmaceutical Sciences
  • Tokyo Women's Medical University
  • Department of Medicine
  • Division of Cell Signaling Regulation
  • Genome
  • Division of Immunobiology
  • The University of Tokyo

External person

Chizuko Hattori

  • Osaka University
  • Graduate School of Pharmaceutical Sciences

External person

Akira Terano

  • Dokkyo Medical University

External person

Shinichi Ota

  • Saitama Medical University

External person

Takeshi Hirakawa

  • European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan

External person

Shin'ichi Takahashi

  • School of Medicine
  • Kyorin University

External person

Min Suk Yang

  • Seoul National University

External person

Hiroshi Ohtsu

  • Japan Society of Clinical Trials and Research

External person

Yuhei Suzuki

  • Department of Medicinal and Life Science
  • Tokyo University of Science

External person

Hajime Hashiba

  • Japan Pharmaceutical Association

External person

Kimie Sai

  • National Institute of Health Sciences Tokyo

External person

Tatsuya Takagi

  • Osaka University
  • Research Institute for Microbial Disease
  • Graduate School of Pharmaceutical Sciences

External person

Kotonari Aoki

  • Federation of Pharmaceutical Manufacturer's Associations of Japan

External person

Ching Lan Cheng

  • National Cheng Kung University

External person

Taku Tsukui

  • Nippon Medical School

External person

Mayumi Mochizuki

  • Division of Evaluation and Analysis of Drug Information
  • Keio University

External person

Hideaki Kurata

  • The Jikei University School of Medicine
  • Division of Cardiology

External person

Yoshihiro Shimodozono

  • Department of Clinical Pharmacy and Pharmacology
  • Kagoshima University

External person